全文获取类型
收费全文 | 49323篇 |
免费 | 4229篇 |
国内免费 | 104篇 |
专业分类
耳鼻咽喉 | 426篇 |
儿科学 | 1255篇 |
妇产科学 | 1188篇 |
基础医学 | 6521篇 |
口腔科学 | 761篇 |
临床医学 | 5062篇 |
内科学 | 9871篇 |
皮肤病学 | 689篇 |
神经病学 | 4609篇 |
特种医学 | 1382篇 |
外国民族医学 | 6篇 |
外科学 | 7127篇 |
综合类 | 1028篇 |
一般理论 | 85篇 |
预防医学 | 4825篇 |
眼科学 | 1171篇 |
药学 | 3789篇 |
中国医学 | 66篇 |
肿瘤学 | 3795篇 |
出版年
2023年 | 254篇 |
2021年 | 838篇 |
2020年 | 582篇 |
2019年 | 1008篇 |
2018年 | 1108篇 |
2017年 | 815篇 |
2016年 | 893篇 |
2015年 | 1074篇 |
2014年 | 1506篇 |
2013年 | 2230篇 |
2012年 | 3094篇 |
2011年 | 3249篇 |
2010年 | 1916篇 |
2009年 | 1673篇 |
2008年 | 2798篇 |
2007年 | 3015篇 |
2006年 | 3086篇 |
2005年 | 3040篇 |
2004年 | 2892篇 |
2003年 | 2578篇 |
2002年 | 2390篇 |
2001年 | 820篇 |
2000年 | 795篇 |
1999年 | 788篇 |
1998年 | 546篇 |
1997年 | 421篇 |
1996年 | 434篇 |
1995年 | 477篇 |
1994年 | 377篇 |
1993年 | 375篇 |
1992年 | 566篇 |
1991年 | 529篇 |
1990年 | 461篇 |
1989年 | 463篇 |
1988年 | 425篇 |
1987年 | 409篇 |
1986年 | 368篇 |
1985年 | 388篇 |
1984年 | 351篇 |
1983年 | 317篇 |
1982年 | 299篇 |
1981年 | 267篇 |
1980年 | 220篇 |
1979年 | 293篇 |
1978年 | 229篇 |
1977年 | 204篇 |
1974年 | 203篇 |
1973年 | 236篇 |
1972年 | 225篇 |
1971年 | 184篇 |
排序方式: 共有10000条查询结果,搜索用时 60 毫秒
1.
2.
3.
Thomas Fuchs-Buder Sorin J. Brull Malin Jonsson Fagerlund J. Ross Renew Guy Cammu Glenn S. Murphy Michiel Warlé Matias Vested Béla Fülesdi Reka Nemes Malachy O. Columb Daniela Damian Peter J. Davis Hajime Iwasaki Lars I. Eriksson 《Acta anaesthesiologica Scandinavica》2023,67(8):994-1017
The set of guidelines for good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents was developed following an international consensus conference in Copenhagen in 1996 (Viby-Mogensen et al., Acta Anaesthesiol Scand 1996, 40 , 59–74); the guidelines were later revised and updated following the second consensus conference in Stockholm in 2005 (Fuchs-Buder et al., Acta Anaesthesiol Scand 2007, 51 , 789–808). In view of new devices and further development of monitoring technologies that emerged since then, (e.g., electromyography, three-dimensional acceleromyography, kinemyography) as well as novel compounds (e.g., sugammadex) a review and update of these recommendations became necessary. The intent of these revised guidelines is to continue to help clinical researchers to conduct high-quality work and advance the field by enhancing the standards, consistency, and comparability of clinical studies. There is growing awareness of the importance of consensus-based reporting standards in clinical trials and observational studies. Such global initiatives are necessary in order to minimize heterogeneous and inadequate data reporting and to improve clarity and comparability between different studies and study cohorts. Variations in definitions of endpoints or outcome variables can introduce confusion and difficulties in interpretation of data, but more importantly, it may preclude building of an adequate body of evidence to achieve reliable conclusions and recommendations. Clinical research in neuromuscular pharmacology and physiology is no exception. 相似文献
4.
5.
6.
7.
8.
Objective
It is useful for reviewers of economic evaluations to assess quality in a manner that is consistent and comprehensive. Checklists can allow this, but there are concerns about their reliability and how they are used in practice. We aimed to describe how checklists have been used in systematic reviews of health economic evaluations.Methods
Meta-review with snowball sampling. We compiled a list of checklists for health economic evaluations and searched for the checklists’ use in systematic reviews from January 2010 to February 2018. We extracted data regarding checklists used, stated checklist function, subject area, number of reviewers, and issues expressed about checklists.Results
We found 346 systematic reviews since 2010 that used checklists to assess economic evaluations. The most common checklist in use was developed in 1996 by Drummond and Jefferson, and the most common stated use of a checklist was quality assessment. Checklists and their use varied within subject areas; 223 reviews had more than one reviewer who used the checklist.Conclusions
Use of checklists is inconsistent. Eighteen individual checklists have been used since 2010, many of which have been used in ways different from those originally intended, often without justification. Different systematic reviews in the same subject areas would benefit from using one checklist exclusively, using checklists as intended, and having 2 reviewers complete the checklist. This would increase the likelihood that results are transparent and comparable over time. 相似文献9.
10.